ASX - By Stock
|
LTP |
Re:
Ann: Investor Presentation
|
|
EV35
|
11 |
2.9K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
11
|
2.9K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
EV35
|
113 |
26K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
26K
|
1
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
EV35
|
113 |
26K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
EV35
|
113 |
26K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
113
|
26K
|
3
|
|
ASX - By Stock
|
UBI |
Re:
Ann: Half Year Results Presentation - 30 June 2022
|
|
EV35
|
9 |
4.6K |
2 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
9
|
4.6K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD
|
|
EV35
|
33 |
11K |
2 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
33
|
11K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD
|
|
EV35
|
33 |
11K |
6 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
33
|
11K
|
6
|
|
ASX - By Stock
|
VNL |
Re:
Ann: Jaxsta Revamps Platform And Launches Business Subscriptions
|
|
EV35
|
17 |
4.2K |
6 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
17
|
4.2K
|
6
|
|
ASX - By Stock
|
VNL |
Re:
Ann: Jaxsta Revamps Platform And Launches Business Subscriptions
|
|
EV35
|
17 |
4.2K |
3 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
17
|
4.2K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Preclinical Success with Targeted Combination Therapies
|
|
EV35
|
20 |
8.6K |
0 |
11/06/22 |
11/06/22 |
ASX - By Stock
|
20
|
8.6K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Preclinical Success with Targeted Combination Therapies
|
|
EV35
|
20 |
8.6K |
1 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
20
|
8.6K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Preclinical Success with Targeted Combination Therapies
|
|
EV35
|
20 |
8.6K |
1 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
20
|
8.6K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Preclinical Success with Targeted Combination Therapies
|
|
EV35
|
20 |
8.6K |
1 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
20
|
8.6K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
We are not a CBD company
|
|
EV35
|
10 |
2.8K |
3 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
10
|
2.8K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
We are not a CBD company
|
|
EV35
|
10 |
2.8K |
3 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
10
|
2.8K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
NTI Chart
|
|
EV35
|
283 |
115K |
3 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
283
|
115K
|
3
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR RAISES $7.5M TO STREAMLINE CLIENT ONBOARDING
|
|
EV35
|
67 |
30K |
6 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
67
|
30K
|
6
|
|
ASX - By Stock
|
CCR |
Re:
Ann: CCR RAISES $7.5M TO STREAMLINE CLIENT ONBOARDING
|
|
EV35
|
67 |
30K |
1 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
67
|
30K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
We are not a CBD company
|
|
EV35
|
10 |
2.8K |
1 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
10
|
2.8K
|
1
|
|
ASX - By Stock
|
MDI |
Re:
General discussion
|
|
EV35
|
67 |
22K |
0 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
67
|
22K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
Ann: Results of Entitlement Offer
|
|
EV35
|
3 |
1.4K |
2 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
EV35
|
29 |
11K |
0 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
29
|
11K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
Ann: Fully Underwritten $20 million Entitlement Offer - Update
|
|
EV35
|
6 |
2.8K |
0 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
6
|
2.8K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
Ann: UBI - Capital Raising
|
|
EV35
|
12 |
6.3K |
0 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
12
|
6.3K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
Ann: UBI - Capital Raising
|
|
EV35
|
12 |
6.3K |
3 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
12
|
6.3K
|
3
|
|
ASX - By Stock
|
AV1 |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
EV35
|
7 |
3.8K |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
7
|
3.8K
|
1
|
|
ASX - By Stock
|
SHE |
Re:
Ann: Quarterly Activity and Cashflow Reports
|
|
EV35
|
226 |
54K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
226
|
54K
|
0
|
|
ASX - By Stock
|
CLE |
Re:
Oh my Gosh, CLE is up
|
|
EV35
|
2 |
2.6K |
2 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
2
|
2.6K
|
2
|
|
ASX - By Stock
|
UBI |
Re:
Ann: UBI - Capital Raising
|
|
EV35
|
12 |
6.3K |
1 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
12
|
6.3K
|
1
|
|
ASX - By Stock
|
UBI |
Re:
Ann: UBI - Capital Raising
|
|
EV35
|
12 |
6.3K |
5 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
12
|
6.3K
|
5
|
|
ASX - By Stock
|
AV1 |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
EV35
|
7 |
3.8K |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
7
|
3.8K
|
4
|
|
ASX - By Stock
|
UBI |
Re:
Ann: Trading Halt
|
|
EV35
|
3 |
1.7K |
5 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
3
|
1.7K
|
5
|
|
ASX - By Stock
|
AV1 |
Re:
Ann: Trading Halt
|
|
EV35
|
9 |
4.3K |
0 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
9
|
4.3K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
UBI General
|
|
EV35
|
31 |
18K |
1 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
31
|
18K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
EV35
|
29 |
11K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
29
|
11K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
EV35
|
29 |
11K |
2 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
EV35
|
29 |
11K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
EV35
|
29 |
11K |
2 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
RNX |
Re:
The journey so far for RNX
|
|
EV35
|
83 |
27K |
5 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
83
|
27K
|
5
|
|
ASX - By Stock
|
RNX |
Re:
The journey so far for RNX
|
|
EV35
|
83 |
27K |
5 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
83
|
27K
|
5
|
|
ASX - By Stock
|
NHE |
Re:
Next Investors New Investment
|
|
EV35
|
69 |
50K |
3 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
69
|
50K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Time to Buy ?
|
|
EV35
|
40 |
12K |
0 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
RNX |
Re:
The journey so far for RNX
|
|
EV35
|
83 |
27K |
4 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
83
|
27K
|
4
|
|
ASX - By Stock
|
EFE |
Re:
EFE 2022 General Discussion
|
|
EV35
|
1.1K |
376K |
7 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.1K
|
376K
|
7
|
|
ASX - By Stock
|
NHE |
Re:
Next Investors New Investment
|
|
EV35
|
69 |
50K |
1 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
69
|
50K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Next Investors New Investment
|
|
EV35
|
69 |
50K |
1 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
69
|
50K
|
1
|
|
ASX - By Stock
|
RNX |
Re:
The journey so far for RNX
|
|
EV35
|
83 |
27K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
83
|
27K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Medicinal Cannabis Presentation
|
|
EV35
|
6 |
2.1K |
2 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
6
|
2.1K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Medicinal Cannabis Presentation
|
|
EV35
|
6 |
2.1K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
UBI |
Re:
UBI General
|
|
EV35
|
31 |
18K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
31
|
18K
|
1
|
|